Nuvectis Pharma (NVCT) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.41
-0.36
-0.3
-0.25

Details

Expected EPS
-0.26
Actual EPS
-0.262
Surprise EPS
-0
Surprise Percent
+0.77%

Description

Nuvectis Pharma (NVCT) has reported earnings of -0.262 per share for Q3 2024.

0 Comments

Share your thoughts